9 Recruiting Severe Aplastic Anemia Phase 2 Clinical Trials
Active phase 2 studies for severe aplastic anemia enrolling across the USA. Verify eligibility and contact site coordinators.
All Severe Aplastic Anemia studiesPhase 2 Studies for Severe Aplastic Anemia
🔵 Active, Not Recruiting Phase2
Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
📍 National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
📍 Blood and Marrow Transplant Group of Georgia — Atlanta, Georgia
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2
Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
📍 University of Maryland, Baltimore (UMB) — Baltimore, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
📍 University of Minnesota Masonic Cancer Center — Minneapolis, Minnesota
View Study & Checklist ➔ 🟢 Recruiting Phase2
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔